solid tumors - Robuta Search

https://www.clinicbarcelona.org/en/idibaps/research-organization/cancer/molecular-pathology-of-inflammatory-conditions-and-solid-tumours Míriam Cuatrecasas - Molecular pathology of inflammatory conditions and solid tumors | IDIBAPS The goal of the group of Dr Míriam Cuatrecasas, Molecular pathology of inflammatory conditions and solid tumors, is molecular pathology inflammatory conditions solid tumors cuatrecasas https://nypedscbc.org/solid-tumors-2/ Solid Tumors – Childrens and Adolescent Cancer & Blood Diseases Center solid tumors blood diseases childrens adolescent cancer https://www.creative-biogene.com/blog/m1-c-lnps-can-serve-as-an-optimal-nanoplatform-for-effective-genetic-immunotherapy-of-solid-tumors M1-C-LNPs Can Serve as An Optimal Nanoplatform for Effective Genetic Immunotherapy of Solid Tumors... This study developed bifunctional M1-C-LNPs containing Bcl2-siRNA and immunomodulatory cytokines to combine gene therapy and immunotherapy for cancer treatment. solid tumors lnps serve optimal nanoplatform https://cme.uchicago.edu/EFPM-DecV2024 Establishing Frameworks for Precision Medicine in NTRK Fusion-Positive Advanced Solid Tumors |... Webinar Using expert-developed, peer-reviewed content, leaders at cancer centers will facilitate a 1-hour learning and action planning program with their... precision medicine solid tumors establishing frameworks ntrk https://www.cgtlive.com/view/initial-results-ct-0508-her2-solid-tumors-reiss-binder Initial Results of CT-0508 in HER2+ Solid Tumors: Kim A. Reiss Binder, MD | CGTlive® Oct 6, 2026 - The oncologist from Abramson Cancer Center, Penn Medicine discussed the initial results of the phase 1 trial of CT-0508 in HER2-overexpressing solid tumors. solid tumors initial results kim reiss https://www.onclive.com/view/zongertinib-displays-early-activity-and-tolerability-in-her2-mutated-solid-tumors Zongertinib Displays Early Activity and Tolerability in HER2-Mutated Solid Tumors | OncLive Oct 8, 2026 - Zongertinib showed responses across HER2-mutated tumor types, including in lung cancer, with a tolerable safety profile. solid tumors zongertinib displays early activity https://biowest.net/es/articulos/harnessing-macrophage-drug-conjugates-for-allogeneic-cell-based-therapy-of-solid-tumors-via-the-train-mechanism-2/ Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the... Authors Bartlomiej Taciak, Maciej Bialasek, Malgorzata Kubiak, Ilona Marszalek1, Malgorzata Gorczak, Olha Osadchuk1, Daria Kurpiel1, Damian Strzemecki1,... solid tumors harnessing macrophage drug conjugates https://www.biospace.com/press-releases/immunos-therapeutics-reports-promising-clinical-activity-of-ios-1002-in-advanced-solid-tumors ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors -... Oct 20, 2025 - · Partial remissions and complete metabolic responses in PD-1/PD-L1-resistant cancers · First-in-class multi-checkpoint inhibitor with robust efficacy and... solid tumors therapeutics reports promising clinical https://inmuno.es/index.php/2025/04/16/targeting-cancer-associated-glycosylation-for-adoptive-t-cell-therapy-of-solid-tumors/ Targeting cancer-associated glycosylation for adoptive T cell therapy of solid tumors – InmunoES t cell solid tumors targeting cancer associated https://healthbook.org/events/annual-symposium-on-antibody-drug-conjugates-in-solid-tumors Annual Symposium on Antibody Drug Conjugates (ADCs) in Solid Tumors | healthbook solid tumors annual symposium antibody drug https://biotechhunter.com/trials/NCT07192120 NCT07192120 - A Study of MHB048C in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech... View clinical trial NCT07192120 details a study solid tumors patients advanced biotech https://mechanocontrol.eu/iproteos-ibec-and-vhir-to-develop-an-innovative-therapy-against-solid-tumors/ Iproteos, IBEC and VHIR to develop an innovative therapy against solid tumors – MECHANO·CONTROL solid tumors ibec develop innovative therapy https://biowest.net/de/artikel/harnessing-macrophage-drug-conjugates-for-allogeneic-cell-based-therapy-of-solid-tumors-via-the-train-mechanism-3/ Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the... Authors Bartlomiej Taciak, Maciej Bialasek, Malgorzata Kubiak, Ilona Marszalek1, Malgorzata Gorczak, Olha Osadchuk1, Daria Kurpiel1, Damian Strzemecki1,... solid tumors harnessing macrophage drug conjugates https://www.mayo.edu/research/clinical-trials/cls-20532376?&p=1 A Dose Escalation Study Of HFB301001 In Adult Patients With Advanced Solid Tumors - Mayo Clinic a dose solid tumors mayo clinic escalation study https://www.oncnursingnews.com/view/investigators-inch-closer-to-unlocking-car-t-cell-therapy-potential-in-solid-tumors Investigators Inch Closer to Unlocking CAR T-Cell Therapy Potential in Solid Tumors | Oncology... Oct 10, 2026 - Findings from a phase 1 trial evaluating CAR T-cell therapy in patients with solid tumors showed promising clinical benefit with the treatment strategy. car t cell closer to solid tumors investigators inch https://rjwaldmann.blogspot.com/2018/12/some-thoughts-on-immunotherapy-of-solid.html?showComment=1674401115822 Robert's Stochastic thoughts: Some Thoughts on Immunotherapy of Solid Tumors solid tumors robert stochastic thoughts immunotherapy https://www.astct.org/Nucleus/Article/meet-the-author-roisin-e-ocearbhaill-md-advancing-cell-therapies-for-solid-tumors-a-pathway-to-overcome-biological-operational-and-regulatory-hurdles Meet the Author: Roisin E. O'Cearbhaill, MD — ‘Advancing Cell Therapies for Solid Tumors: A Pathway... the author solid tumors meet roisin cell https://twgbreastcancer.com/2023/11/26/six-months-after-second-pfizer-vaccine-dose-people-with-solid-tumors-have-same-covid-19-antibody-levels-as-people-without-cancer-2/ Six Months After Second Pfizer Vaccine Dose, People With Solid Tumors Have Same COVID-19 Antibody... If you’re currently receiving breast cancer treatment and are worried about how effective a COVID-19 vaccine may be for you, this study offers reassuring... pfizer vaccine solid tumors six months second https://usoncology.com/patients/clinical-trials/23328-solid-tumors-na-1529/ 23328-Solid Tumors-NA-1529 - The US Oncology Network solid tumors the us oncology network https://hospitalcredentialinghub.com/job/vice-president-global-medical-affairs-solid-tumors-raritan-nj-johnson-johnson-medtech/ Vice President Global Medical Affairs, Solid Tumors – Raritan, NJ (Johnson & Johnson MedTech) -... vice president medical affairs solid tumors global raritan https://www.bmsstudyconnect.com/br/en/clinical-trials/NCT00516451.html Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors | BMS Study Connect The purpose of this clinical study is to identify the maximum tolerated dose (MTD) of BMS-690514 once daily orally in Japanese subjects with advanced or... phase i study in japanese solid tumors bms patients https://www.targetedonc.com/view/ly3537982-shows-preliminary-efficacy-in-kras-g12c-mutated-solid-tumors LY3537982 Shows Preliminary Efficacy in KRAS G12C-Mutated Solid Tumors | Targeted Oncology -... Oct 7, 2026 - In an interview with Targeted Oncology, Joshua Sabari, MD, discussed the rationale of studying LY3537982 in the LOXO-RAS-20001 trial and next steps for the... solid tumors shows preliminary efficacy kras https://www.trialx.com/clinical-trials/listings/231255/a-phase-12-study-6/ A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors | Clinical Research Trial Listing ( Advanced... Clinical trial for Advanced Solid Tumor , A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors clinical research trial solid tumors phase study advanced https://solid-tumors-tuebingen.com/hotel-reservation/ Hotel Reservation | 10th International Tuebingen Symposium on Pediatric Solid Tumors & SIOPEL... hotel reservation solid tumors international tuebingen symposium https://rssfeeds.cloudsite.builders/2026/07/10/car-t-revolutionized-how-we-treat-blood-cancers-now-its-closing-in-on-solid-tumors/ CAR T Revolutionized How We Treat Blood Cancers. Now It’s Closing In on Solid Tumors. - RSS Feeds... Jul 10, 2026 - Separate teams discovered the same target in solid cancers, enabling a powerful two-pronged attack on both tumors and the cells shielding them. closing in on blood cancers solid tumors rss feeds car https://www.kennethresearch.com/report-details/global-ntrk-fusion-gene-positive-advanced-solid-tumor-market/10347506 Global NTRK Fusion Gene Positive Advanced Solid Tumors Market Size study, by Type (By Therapeutics,... Global NTRK Fusion Gene Positive Advanced Solid Tumor market Insights includes market share, market research report, market trade, market prices, market... fusion gene solid tumors market size by type global https://www.turkradyolojiseminerleri.org/articles/imaging-of-renal-solid-tumors-renal-cell-carcinoma-and-others/doi/trs.2024.24143 Imaging of Renal Solid Tumors: Renal Cell Carcinoma and Others - Türk Radyoloji Seminerleri Imaging of Renal Solid Tumors: Renal Cell Carcinoma and Others - Türk Radyoloji Seminerleri solid tumors imaging renal cell carcinoma https://www.parissaclaycancercluster.org/event-details/pre-analytical-workflow-for-solid-tumors-and-liquid-biopsies-the-role-of-automation-in-molecular-oncology-diagnostics Pre-analytical Workflow for Solid Tumors and Liquid Biopsies: The Role of Automation in Molecular... solid tumors liquid biopsies the role pre analytical https://researchinformation.umcutrecht.nl/en/publications/biomarker-driven-immunotherapy-in-patients-with-advanced-solid-tu/ Biomarker-driven Immunotherapy in Patients with Advanced Solid Tumors: Providing Access and... solid tumors biomarker driven immunotherapy patients https://mouseion.jax.org/stfb2026/104/ "Temsirolimus in Patients With Solid Tumors With" by Evan Pisick, Michael Rothe et al. Purpose TAPUR is a phase II basket trial evaluating the antitumor activity of commercially available targeted agents in patients with advanced cancer and... solid tumors michael rothe et al temsirolimus patients https://www.techtransfer.nih.gov/patent/e-024-2009-0-gb-13 GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS | Technology Transfer gene signature solid tumors technology transfer predicting prognosis https://rjwaldmann.blogspot.com/2018/12/some-thoughts-on-immunotherapy-of-solid.html?showComment=1693303420089 Robert's Stochastic thoughts: Some Thoughts on Immunotherapy of Solid Tumors solid tumors robert stochastic thoughts immunotherapy https://www.muni.cz/en/research/publications/815972 The identification of cells with cancer stem cell phenotype in pediatric solid tumors. | Masaryk... cancer stem cell solid tumors identification cells phenotype https://www.mayo.edu/research/clinical-trials/cls-20572700?&p=1 Study Of RAS(ON) Inhibitors In Patients With Gastrointestinal Solid Tumors - Mayo Clinic solid tumors mayo clinic study ras inhibitors https://www.allclinicaltrials.com/study/NCT01050296 Molecular Analysis Of Solid Tumors This study will prospectively characterize the molecular, cellular and genetic properties of primary and metastatic neuroblastoma, osteosarcoma,... molecular analysis solid tumors https://www.geneediting.com/clinical-trials/NCT07813000/ NCT07813000: Physician and Patient Preferences for Cell Therapies in Advanced Solid Tumors |... Cell therapies - including chimeric antigen receptor T-cell (CAR-T) therapy, tumor-infiltrating lymphocyte (TIL) therapy, T-cell receptor-engineered T-cell... solid tumors physician patient preferences cell https://medicine.washu.edu/news/medicare-approves-genetic-test-for-solid-tumors/ Medicare approves genetic test for solid tumors – WashU Medicine Feb 22, 2024 - Test can quickly identify treatable cancer mutations, guide precision therapy genetic test solid tumors medicare approves washu https://www.bmsclinicaltrials.com/de/de/clinical-trials/NCT05578092 A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway | BMS... This is a Phase 1/2, open-label, multicenter, study evaluating the safety, tolerability, PK, PD, and anti-tumor activity of MRTX0902 alone and in combination... solid tumors phase study mutations kras https://blogs.bmj.com/bmj/2019/11/05/unreported-trial-of-the-week-orally-administered-ag-221-in-subjects-with-advanced-solid-tumours-nct02273739/ Unreported clinical trial of the week: Enasidenib for use in advanced solid tumors (NCT02273739) -... Nov 11, 2019 - Peter Grabitz, Merlin Bittlinger, Ben Goldacre, Nicholas J. DeVito Background The US Food and Drug Administration (FDA) Amendments Act (FDAAA 2007) requires... clinical trial of the solid tumors unreported week https://jscholaronline.org/full-text/JOCR/6_102/Phase-I-Study-of-Lurbinectedin-in-Japanese-Patients.php Phase I Study of Lurbinectedin in Japanese Patients with Pretreated Advanced Solid Tumors Jscholar is an open access publisher of peer reviewed journals and research articles, which are free to access, share and distribute for the advancement of... phase i study in japanese solid tumors lurbinectedin patients https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT04471415&r=1 Study to Investigate DRP-104 in Adults With Advanced Solid Tumors - NCI Study to Investigate DRP-104 in Adults With Advanced Solid Tumors solid tumors study investigate drp adults https://www.biohavenclinicaltrials.com/clinical-studies/advanced-tumors/ Advanced or Metastatic Solid Tumors Study | Biohaven Clinical Trials Sep 8, 2026 - BHV-1530 is being studied in patients with Advanced or Metastatic Solid Tumors. Visit to learn more. solid tumors clinical trials advanced metastatic study https://beattheoddsfund.org/find-care/trials/NCT06638931 Agnostic Therapy in Rare Solid Tumors · Sarcoma Trials · Beat the Odds NCT06638931 (Phase 2). Sponsor: Instituto do Cancer do Estado de São Paulo. Information from ClinicalTrials.gov. beat the odds solid tumors agnostic therapy rare https://fecri.org.au/publication/dose-intensive-cyclophosphamide-with-etoposide-and-vincristine-for-paediatric-solid-tumors-a-phase-i-ii-pilot-study-by-the-australia-and-new-zealand-childhood-cancer-study-group/ Dose-intensive cyclophosphamide with etoposide and vincristine for pediatric solid tumors: a phase... solid tumors dose intensive cyclophosphamide etoposide